← Back to Search

Medication counseling for Medication Management

N/A
Waitlist Available
Led By Alison Carroll, MD
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during follow-up survey assessment 48-72 hours following patient/child discharge from the hospital
Awards & highlights

Study Summary

This trial is testing whether a health-literacy-informed intervention can reduce medication dosing errors and improve adherence in hospitalized children discharged on a new liquid medication.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during follow-up survey assessment 48-72 hours following patient/child discharge from the hospital
This trial's timeline: 3 weeks for screening, Varies for treatment, and during follow-up survey assessment 48-72 hours following patient/child discharge from the hospital for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Observed dosing accuracy
Reported dosing accuracy
Secondary outcome measures
Caregiver medication frequency comprehension
Caregiver medication indication comprehension
Caregiver medication name comprehension
Other outcome measures
Caregiver medication duration adherence
Caregiver medication duration comprehension
Caregiver medication frequency adherence
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Participants in the intervention group will receive supplementary medication discharge instructions in addition to the standard communications. They will receive instructions on how to submit information and complete study surveys securely through their cellphones during their child's home treatment period.
Group II: ControlActive Control1 Intervention
Participants in the usual care group will receive standard-of-care discharge communications per unit routine, including counseling regarding prescribed medications and post-discharge instructions, return precautions, and follow-up appointments by the pediatric nursing staff.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Medication counseling
2021
N/A
~990

Find a Location

Who is running the clinical trial?

The Gerber FoundationOTHER
41 Previous Clinical Trials
5,844 Total Patients Enrolled
Vanderbilt University Medical CenterLead Sponsor
856 Previous Clinical Trials
672,005 Total Patients Enrolled
Alison Carroll, MDPrincipal InvestigatorVanderbilt University Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still opportunities to take part in this clinical exploration?

"According to clinicaltrials.gov, this clinical trial is currently not enrolling participants - the study was initially posted on June 25th 2021 and last updated on September 28th 2022. However, there are still 1 other studies actively recruiting now."

Answered by AI
~40 spots leftby Apr 2025